Add to ORKGIntroduction and Aims: Marinobufagenin is a causal factor in the genesis of uremic cardiomyopathy; it induces fibrosis, and its production is stimulated by the renin-angiotensin system. The purpose of the present study was to clarify whether the levels of circulating marinobufagenin are decreased by treatment of heart remodeling in subtotally nephrectomized rats usin
Hypertension is a leading cause of cardiovascular disease and myocardial infarction (MI), and these ...
BackgroundMarinobufagenin (MBG) is an endogenous cardiotonic steroid (CTS) that inhibits the Na+/K+-...
The cardiotonic steroid marinobufagenin (MBG) has been implicated in the pathogenesis of experimenta...
Background Cardiotonic steroids (CTS) are implicated in pathophysiology of uremic cardiomyopathy. In...
Patients with chronic renal failure develop a “uremic” cardiomyopathy characterized by diastolic dys...
We have observed recently that experimental renal failure in the rat is accompanied by increases in ...
BackgroundChronic kidney disease (CKD) causes congestive heart failure (CHF) with systolic dysfuncti...
Cardiotonic steroids, including marinobufagenin, are a group of new steroid hormones found in plasma...
Cardiotonic steroids, including marinobufagenin, are a group of new steroid hormones found in plasma...
BACKGROUND We have shown that the cardiotonic steroid marinobufagenin (MBG) is elevated in clinical ...
We recently demonstrated that the cardiotonic steroid marinobufagenin (MBG) induced fibrosis in rat ...
We recently demonstrated that the cardiotonic steroid marinobufagenin (MBG) induced fibrosis in rat ...
Left ventricular hypertrophy with diffuse intermyocardiocytic fibrosis is a feature of uremia. The r...
Hypertension is a leading cause of cardiovascular disease and myocardial infarction (MI), and these ...
The cardiotonic steroid marinobufagenin (MBG) has been implicated in the pathogenesis of experimenta...
Hypertension is a leading cause of cardiovascular disease and myocardial infarction (MI), and these ...
BackgroundMarinobufagenin (MBG) is an endogenous cardiotonic steroid (CTS) that inhibits the Na+/K+-...
The cardiotonic steroid marinobufagenin (MBG) has been implicated in the pathogenesis of experimenta...
Background Cardiotonic steroids (CTS) are implicated in pathophysiology of uremic cardiomyopathy. In...
Patients with chronic renal failure develop a “uremic” cardiomyopathy characterized by diastolic dys...
We have observed recently that experimental renal failure in the rat is accompanied by increases in ...
BackgroundChronic kidney disease (CKD) causes congestive heart failure (CHF) with systolic dysfuncti...
Cardiotonic steroids, including marinobufagenin, are a group of new steroid hormones found in plasma...
Cardiotonic steroids, including marinobufagenin, are a group of new steroid hormones found in plasma...
BACKGROUND We have shown that the cardiotonic steroid marinobufagenin (MBG) is elevated in clinical ...
We recently demonstrated that the cardiotonic steroid marinobufagenin (MBG) induced fibrosis in rat ...
We recently demonstrated that the cardiotonic steroid marinobufagenin (MBG) induced fibrosis in rat ...
Left ventricular hypertrophy with diffuse intermyocardiocytic fibrosis is a feature of uremia. The r...
Hypertension is a leading cause of cardiovascular disease and myocardial infarction (MI), and these ...
The cardiotonic steroid marinobufagenin (MBG) has been implicated in the pathogenesis of experimenta...
Hypertension is a leading cause of cardiovascular disease and myocardial infarction (MI), and these ...
BackgroundMarinobufagenin (MBG) is an endogenous cardiotonic steroid (CTS) that inhibits the Na+/K+-...
The cardiotonic steroid marinobufagenin (MBG) has been implicated in the pathogenesis of experimenta...